News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Intelsius Celebrates 15 Years of Protecting Life's Most Precious Cargo™


1/15/2013 9:23:41 AM

YORK, England, Jan. 15, 2013 /PRNewswire/ -- Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, announces the launch of its 15th Anniversary Celebration year.

(Logo: http://photos.prnewswire.com/prnh/20120215/DE53620LOGO)

"We are delighted to announce this milestone and intend to make it our most successful year ever," said founder David Walsh, chief executive officer of Intelsius. "The answer to one problem created a new company that began making temperature controlled, regulatory compliant packaging 15 years ago and continues to create innovative solutions today."

Intelsius was incorporated as DGP Group in 1998, when the company developed a unique packaging solution designed for the transportation of samples suspected of containing the BSE (Bovine Spongiform Encephalitis, or "Mad Cow Disease") prion. Within one year DGP Group commercialized the first UN-certified TSE/BSE sample shipper in the world.

The company, rebranded as Intelsius in 2010, has grown from three partners and expanded with offices and manufacturing facilities throughout the world including Europe, North America and Asia. Intelsius now serves a wide range of organizations, including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries, to major laboratories.

Intelsius temperature-controlled packaging systems (-70 degrees C, -20 degrees C, 2-8 degrees C and 15-25 degrees C) meet or exceed WHO, ISTA, IATA perishable goods and USP1079 standards. In addition, where applicable, they comply with UN dangerous goods regulatory performance requirements. Intelsius, at the cutting edge of temperature control technology, maintains an ISTA-certified laboratory and has hundreds of innovative solutions to its credit. All Intelsius products are supported by proprietary temperature and excursion risk assessment software; ATMOS.

"Intelsius will continue to push the design envelope, developing solutions and technological services unavailable elsewhere in the temperature-controlled packaging industry," said Walsh. "Patient safety has always been at the forefront of our minds, these last 15 years. This is a great opportunity to renew our commitment to listening to our clients, being responsive to their needs, and ultimately striving to anticipate their needs before they arise."

About Intelsius

Intelsius is a subsidiary of DGP Life Science Ltd, which is headquartered in York, United Kingdom. With a strong focus on developing environmentally sustainable products and procedures, the company offers solutions to ensure the integrity of customers' products and samples. Intelsius has a growing global presence with manufacturing facilities, distribution hubs and offices situated throughout the world. For more information, visit www.intelsius.com.

SOURCE Intelsius


Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES